IND - Investigational New Drug

IND - Investigational New Drug

Sickle Cell Disease, SCD (NCT05456880)
Sponsors:
Beam Therapeutics
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Solid Tumours, EDIT-201
Discontinued


Sponsors:
Editas Medicine 
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine